Allianz Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Sell
14,600
-28,007
-66% -$4.31M ﹤0.01% 1492
2025
Q4
$7.42M Sell
42,607
-23,476
-36% -$4.28M 0.01% 962
2025
Q3
$9.52M Sell
66,083
-14,339
-18% -$1.76M 0.01% 862
2025
Q2
$8.09M Buy
80,422
+5,138
+7% +$393K 0.01% 892
2025
Q1
$5.74M Buy
75,284
+3,534
+5% +$270K 0.01% 1035
2024
Q4
$4.95M Sell
71,750
-33,927
-32% -$2.44M 0.01% 1052
2024
Q3
$7.71M Sell
105,677
-9,500
-8% -$701K 0.01% 842
2024
Q2
$7.72M Buy
115,177
+24,500
+27% +$950K 0.01% 787
2024
Q1
$2.46M Buy
90,677
+61,677
+213% +$1.73M ﹤0.01% 1116
2023
Q4
$899K Buy
29,000
+6,600
+29% +$171K ﹤0.01% 1640
2023
Q3
$566K Sell
22,400
-3,900
-15% -$89.2K ﹤0.01% 1881
2023
Q2
$555K Hold
26,300
﹤0.01% 1708
2023
Q1
$448K Hold
26,300
﹤0.01% 1918
2022
Q4
$525K Sell
26,300
-12,700
-33% -$245K ﹤0.01% 1717
2022
Q3
$840K Sell
39,000
-266,635
-87% -$6.39M ﹤0.01% 1446
2022
Q2
$6.03M Buy
305,635
+151,859
+99% +$3.18M 0.01% 1045
2022
Q1
$3.61M Buy
153,776
+44,841
+41% +$1.04M ﹤0.01% 1348
2021
Q4
$2.97M Buy
108,935
+7,855
+8% +$225K ﹤0.01% 1457
2021
Q3
$2.78M Buy
101,080
+68,940
+214% +$1.81M ﹤0.01% 1513
2021
Q2
$914K Buy
32,140
+9,445
+42% +$280K ﹤0.01% 1777
2021
Q1
$773K Hold
22,695
﹤0.01% 1743
2020
Q4
$755K Hold
22,695
﹤0.01% 1549
2020
Q3
$730K Sell
22,695
-7,983
-26% -$229K ﹤0.01% 1516
2020
Q2
$845K Sell
30,678
-21,251
-41% -$504K ﹤0.01% 1874
2020
Q1
$833K Sell
51,929
-7,584
-13% -$180K ﹤0.01% 1864
2019
Q4
$1.42M Sell
59,513
-118,532
-67% -$2.41M ﹤0.01% 2037
2019
Q3
$3.17M Sell
178,045
-31,595
-15% -$610K ﹤0.01% 1640
2019
Q2
$5.37M Sell
209,640
-59,279
-22% -$1.65M 0.01% 1466
2019
Q1
$7.82M Buy
268,919
+126,001
+88% +$3.27M 0.01% 1248
2018
Q4
$1.87M Sell
142,918
-38,477
-21% -$614K ﹤0.01% 1793
2018
Q3
$3.67M Buy
181,395
+102,745
+131% +$2.32M ﹤0.01% 1695
2018
Q2
$1.86M Buy
+78,650
New +$2.02M ﹤0.01% 1976
2015
Q4
Sell
-74,426
Closed -$1.38M 2474
2015
Q3
$1.38M Buy
74,426
+1,389
+2% +$34.7K ﹤0.01% 1713
2015
Q2
$1.78M Sell
73,037
-78
-0.1% -$1.77K ﹤0.01% 1748
2015
Q1
$1.52M Sell
73,115
-13,882
-16% -$245K ﹤0.01% 1641
2014
Q4
$1.35M Sell
86,997
-688
-0.8% -$9.76K ﹤0.01% 1717
2014
Q3
$1.14M Sell
87,685
-4,359
-5% -$65.7K ﹤0.01% 1624
2014
Q2
$1.84M Buy
92,044
+7,839
+9% +$116K ﹤0.01% 1232
2014
Q1
$1.6M Sell
84,205
-5,109
-6% -$97.1K ﹤0.01% 1281
2013
Q4
$1.52M Sell
89,314
-5,176
-5% -$79.3K ﹤0.01% 1287
2013
Q3
$1.48M Buy
+94,490
New +$1.2M ﹤0.01% 1281

Other funds holding INSM

Allianz Asset Management's INSM Position: Q1 2026 in Review

Allianz Asset Management reduced its Insmed (INSM) stake by 66% in Q1 2026, selling an estimated $4.31M and leaving 14,600 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Allianz Asset Management first reported a position in INSM in Q3 2013 and has held it in 41 quarters since. The position peaked at $9.52M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Allianz Asset Management held 14,600 shares of Insmed worth $2.39M as of Q1 2026.
  • Allianz Asset Management sold 28,007 Insmed shares in Q1 2026, an estimated $4.31M.
  • Insmed made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1492 holding.
  • Allianz Asset Management first reported a position in Insmed in Q3 2013 and has held it in 41 quarters since.
  • Allianz Asset Management's Insmed position peaked at $9.52M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.